19-1220488-G-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The NM_000455.5(STK11):c.580G>T(p.Asp194Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D194E) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000455.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
STK11 | NM_000455.5 | c.580G>T | p.Asp194Tyr | missense_variant | 4/10 | ENST00000326873.12 | |
STK11 | NM_001407255.1 | c.580G>T | p.Asp194Tyr | missense_variant | 4/9 | ||
STK11 | NR_176325.1 | n.1847G>T | non_coding_transcript_exon_variant | 5/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
STK11 | ENST00000326873.12 | c.580G>T | p.Asp194Tyr | missense_variant | 4/10 | 1 | NM_000455.5 | P1 |
Frequencies
GnomAD3 genomes ? Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1453080Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 722078
GnomAD4 genome ? Cov.: 33
ClinVar
Submissions by phenotype
Melanoma Pathogenic:1
Likely pathogenic, no assertion criteria provided | literature only | Database of Curated Mutations (DoCM) | May 13, 2016 | - - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 30, 2020 | The p.D194Y pathogenic mutation (also known as c.580G>T), located in coding exon 4 of the STK11 gene, results from a G to T substitution at nucleotide position 580. The aspartic acid at codon 194 is replaced by tyrosine, an amino acid with highly dissimilar properties. This alteration has been reported in an individual with a clinical diagnosis of Peutz-Jeghers syndrome (PJS) (Zheng B et al. J Pediatr Gastroenterol Nutr, 2017 04;64:559-564). Two other alterations at the same codon, p.D194N (c.580G>A) and p.D194E (c.582C>A), have been described in multiple families meeting clinical diagnostic criteria for PJS (Westerman AM et al. Hum. Mutat. 1999;13:476-81; Lim W et al. Br. J. Cancer. 2003 Jul;89:308-13; Schumacher V et al. J. Med. Genet. 2005 May;42:428-35; Hearle NC et al. J. Med. Genet. 2006 Apr;43:e15; Chow E et al. Clin. Genet. 2006 Nov;70:409-14; Klumpen, HJ et al. J Clin Oncol. 2011 Feb 20;29(6):e150-3; Korsse, SE et al. J Med Genet. 2013 Jan;50(1):59-64; Borun P et al. BMC Med. Genet. 2013 May;14:58; Jiang YL et al. Cancer Genet. 2019 01;230:47-57). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). In one functional study, this alteration demonstrated reduced kinase activity compared to wildtype (Granado-Martínez P et al. Commun Biol, 2020 Jul;3:366). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. - |
Melanoma, cutaneous malignant, susceptibility to, 1 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 04, 1999 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at